ANXA5 and acute myeloid leukemia: We first assessed the sensitivity of the AML cell lines to Ara-C, ABT-199, Nutlin-3a, and KPT-330 by determining the fraction of annexin V positive cells and absolute numbers of Annexin V- and propidium iodide-negative live cells after 48 hour treatment (Fig 1).